Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Description

The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.

Conditions

Coagulopathy

Study Overview

Study Details

Study overview

The goal of this observational study is to learn about the performance of the TEG6s in normal pediatric patients. The main questions it aims to answer are: What are the normal TEG 6S lab results in normal pediatric patients and how do they compare to existing published reference ranges. Participants and their guardians will be asked to submit a small amount of blood at the beginning of an elective operation for analysis in the TEG 6s machine.

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients

Condition
Coagulopathy
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Riley Hospital for Children, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Known disorder of coagulation pathway(s)
  • * Administration of medications that may alter the coagulation cascade
  • * Patients in foster care or wards of the court

Ages Eligible for Study

3 Months to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Study Record Dates

2025-08